US Stock MarketDetailed Quotes
ORGS Orgenesis
- 0.670
- -0.018-2.60%
Close Aug 30 16:00 ET
- 0.652
- -0.018-2.64%
Post 20:01 ET
31.44MMarket Cap-837P/E (TTM)
0.690High0.653Low86.73KVolume0.690Open0.688Pre Close57.85KTurnover0.32%Turnover RatioLossP/E (Static)46.93MShares1.08052wk High-2.03P/B18.25MFloat Cap0.25052wk Low--Dividend TTM27.25MShs Float16.800Historical High--Div YieldTTM5.38%Amplitude0.250Historical Low0.667Avg Price1Lot Size
About Orgenesis Company
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
Company Profile
SymbolORGS
Company NameOrgenesis
Listing DateMar 13, 2018
Founded2008
CEOMs. Vered Caplan
MarketNASDAQ
Employees146
Fiscal Year Ends12-31
Address20271 Goldenrod Lane
CityGermantown
ProvinceMaryland
CountryUnited States of America
Zip Code20876
Phone1-480-659-6404
Websitehttp://www.orgenesis.com
Company Executives
- Name
- Position
- Salary
- Vered Caplan
- Chairperson of the Board and Chief Executive Officer
- 341.38K
- Victor Miller
- Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer
- --
- Mark Goodman
- Director
- --
- Kevin Choquette
- Director
- --
- Dr. Itzhak Vider
- Independent Director
- --
- Ashish Nanda
- Independent Director
- 69.91K
- Yaron Adler
- Independent Director
- 64.64K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg